Skip to main content
$0.030 (0%)

High

$0.03

Low

$0.03

Trades

25

Turnover

$28,362

Volume

960,646
30 June 2023 at 4:10pm
If you were already registered, log in here.

Short Interest

ASIC data, 12 Dec 2022

% Shorted

0.00% 0.04
vs 0.04% prior report

Most Shorted Rank

692nd
of 717 shorted ASX stocks

Peak Short

0.40%
Jul 2020

Days to Cover

0.0
at 50d avg vol
Subject
LBT Ann: Company Presentation ASX Small and Mid-Cap Conference

LBT Ann: New Data Published on APAS Technology

LBT Ann: Appendix 4G

LBT Ann: Corporate Governance Statement

LBT Ann: Annual Report to shareholders

LBT Ann: Appendix 4E

LBT Ann: Application for quotation of securities - LBT

LBT Ann: Proposed issue of securities - LBT

LBT Ann: Updated Product Pipeline Strategy Announced

LBT Ann: Notification of cessation of securities - LBT

LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report

LBT Ann: APAS Independence Showcased at Major US Microbiology Conf

LBT Ann: Direct Sale of APAS Independence in United States

LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report

LBT Ann: Clinical Data Featuring APAS Technology Presented at ECCMID

LBT Ann: Purchase Order for Multiple APAS Instruments

LBT Ann: Half Yearly Report and Accounts

LBT Ann: LBT Receives $824,500 R&D Tax Incentive

LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report

LBT Ann: Notification regarding unquoted securities - LBT

LBT Ann: Notification of cessation of securities - LBT

LBT Ann: LBT Investor Call to discuss CCS Acquisition

LBT Ann: LBT Completes CCS Acquisition

LBT Ann: Notice of Initial Substantial Holder

LBT Ann: LBT Completes CCS Acquisition

LBT Ann: Appendix 3Y - Simon Arkell

LBT Ann: Appendix 3Y - Damian Lismore

LBT Ann: Appendix 3Y - Brian O'Dwyer

LBT Ann: Appendix 3Y - Joanne Moss

LBT Ann: Notice under Section 708A - Cleansing Notice

LBT Ann: Notification regarding unquoted securities - LBT

LBT Ann: Application for quotation of securities - LBT

LBT Ann: Update - Proposed issue of securities - LBT

LBT Ann: Notification regarding unquoted securities - LBT

LBT Ann: Notification regarding unquoted securities - LBT

LBT Ann: Application for quotation of securities - LBT

LBT Ann: Proposed issue of securities - LBT

LBT Ann: LBT to Obtain Full Ownership of CCS Joint Venture

LBT Ann: Market Update - Sales Pipeline and Evaluations

LBT Ann: Results of Meeting

LBT Ann: CEO Presentation - AGM 2021

LBT Ann: Chair's Address to Shareholders - AGM 2021

LBT Ann: Jobkeeper Payments Notification

LBT Ann: US FDA 510(k) Clearance for MRSA Analysis Module

LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report

LBT Ann: Notice of Annual General Meeting/Proxy Form

LBT Ann: Presentation at Australia Biotech Invest & Partnering 2021

LBT Ann: SA Government Extends Loan Repayment Schedule

LBT Ann: Final Director's Interest Notice

LBT Ann: Kate Costello Retires as Director and Chair of the Board

If you were already registered, log in here.

Similar Companies

AT1
COH
CSX
CYC
EMV
IBX
IPD
MX1
RSH
SOM
S88
MAV
CX8
MTX $12m raise
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS